Add BrightSurf on Google Email

Cancer rates in teens and early 20s rising

Researchers found a significant increase in cancer cases among teenagers and young adults, with certain cancers dominating at different ages. The study suggests that environmental risk factors and genetic susceptibility may play a role in the increasing incidence of adolescent and young adult cancer.

Brain tumor growth requires abnormal neighbors

Researchers developed a mouse model of neurofibromatosis 1 to study brain tumor growth, finding that tumors require permissive environments. Astrocytes with both copies of the Nf1 gene lacking in surrounding cells were found to develop into tumors, highlighting the importance of location in cancer development.

SourceWashU Medicine·JournalCancer Research·DateDec 15, 2003

Modified adenovirus offers new approach to treating aggressive brain tumors

A modified adenovirus, Delta-24-RGD, has shown improved infectivity and replication efficiency compared to the unmodified Delta-24. This leads to increased cytopathic effects and prolonged survival rates in mouse models of human glioma. The authors conclude that Delta-24-RGD may be an effective agent in treating gliomas.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateMay 6, 2003

Exposure to atomic bomb radiation associated with nervous system tumors

A study of Japanese atomic bomb survivors found a significant association between radiation exposure and an increased risk of all nervous system tumors, with higher risks for schwannomas, men, and children. The authors suggest that these increased risks persist throughout lifetime, regardless of age at exposure.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateOct 15, 2002

Researchers track elusive brain tumor cells in mice with neural stem cells modified to deliver IL-12

Scientists have developed a novel treatment using neural stem cells to track and target brain tumor cells that spread into normal brain tissue. The therapy involves genetically engineering neural stem cells to produce interleukin 12, an immune-stimulating chemical known to kill glioma cells. Mice treated with this approach survived sig...

SourceCedars-Sinai Medical Center·JournalCancer Research·DateOct 15, 2002

Cell phones don't cause cancer, rat study finds

A long-term industry-funded rat study has found no statistically significant increases in any tumor type, including brain cancer, after exposure to radio frequency radiation at common cell phone signals. The study builds on earlier research and suggests the greatest hazard with cell-phones is driving a car while talking.

Calcium-dependent potassium channels as target to increase drug delivery to brain tumors

Researchers have identified a mechanism to increase drug delivery to brain tumors by manipulating calcium-dependent potassium channels. The study found that activating these channels can increase the permeability of the blood-brain tumor barrier, allowing cancer-killing medications to reach the tumor more effectively.

SourceCedars-Sinai Medical Center·JournalJournal of Pharmacology and Experimental Therapeutics·DateMay 22, 2002

UF develops radiation-targeting system

Researchers at the University of Florida have developed a new radiation-targeting system that uses advanced imaging and optic guidance techniques to precisely target tumors. The system, now commercially available, aims to minimize damage to surrounding healthy tissues and potentially improve cure rates.

Experimental microbeam radiation therapy may offer improvement over traditional radiation treatments

Researchers have developed a new radiation therapy technique that shows significant improvement over traditional methods in treating brain tumors in infants. The treatment uses high-intensity synchrotron sources to confine x-rays to extremely narrow slices, resulting in reduced damage to surrounding tissue.

SourceDOE/Brookhaven National Laboratory·JournalCellular and Molecular Biology·DateJul 2, 2001

Not a brain tumor: serious headaches explained

Researchers identified enlarged pituitary glands in patients with intracranial hypotension syndrome, a condition characterized by headaches that worsen when sitting up. The condition can be diagnosed through low spinal cord fluid pressure readings and treated with conventional therapies such as bed rest, hydration, and corticosteroids.

SourceAmerican Academy of Neurology·JournalNeurology·DateDec 25, 2000